We have read with interest the recent article, “Role of high-dose intravenous nitrates
in hypertensive acute heart failure” by Wang et al. [
[1]
]. Here, we want to underline some important points to consider and mention from a
study that supporting the article.To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Role of high-dose intravenous nitrates in hypertensive acute heart failure.Am J Emerg Med. 2020; 38 (Jan): 132-137
- Methemoglobinemia produced by high-dose intravenous nitroglycerin.Ann Intern Med. 1982; 96 (May): 615-616
- Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study.J Intern Med. 2010; 267 (Mar): 322-330
- Impact of nitrate use on survival in acute heart failure: a propensity-matched analysis.J Am Heart Assoc. 2016 Feb 12; 5 ([pii: e002531])
- Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial.JAMA. 2019; 322 (Dec 17): 2292-2302https://doi.org/10.1001/jama.2019.18598
Article Info
Publication History
Published online: February 03, 2020
Accepted:
January 29,
2020
Received:
January 19,
2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
